Flubendazole Enhances the Inhibitory Effect of Paclitaxel via HIF1α/PI3K/AKT Signaling Pathways in Breast Cancer

Paclitaxel, a natural anticancer drug, is widely recognized and extensively utilized in the treatment of breast cancer (BC). However, it may lead to certain side effects or drug resistance. Fortunately, combination therapy with another anti-tumor agent has been explored as an option to improve the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yuxin, Liao, Minru, Li, Zixiang, Ye, Jing, Wu, Lifeng, Mou, Yi, Fu, Leilei, Zhen, Yongqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606573/
https://www.ncbi.nlm.nih.gov/pubmed/37894802
http://dx.doi.org/10.3390/ijms242015121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606573/
https://www.ncbi.nlm.nih.gov/pubmed/37894802
http://dx.doi.org/10.3390/ijms242015121

Ejemplares similares